Core Viewpoint - The announcement details the judicial freezing and marking of shares held by the major shareholder's concerted action party, which may impact the company's governance and operations due to high levels of share pledges and judicial actions [2][3][6]. Shareholder Situation - The major shareholder, Zhu Rongjuan, and the concerted action party, Guangxi Guofa Investment Group Co., Ltd., had 691,376 shares marked and frozen as of November 7, 2025, representing 0.13% of the total share capital [2][3]. - Of the shares held by Guangxi Guofa, 512,005 shares were pledged, accounting for 74.06% of their holdings, while all 691,376 shares were judicially frozen [2][3]. - The total shares held by the major shareholder and concerted action parties amounted to 56,181,961 shares, or 10.72% of the total share capital, with 33,835,005 shares pledged (60.22%) and 43,858,961 shares frozen (78.07%) [2][3]. Legal and Financial Issues - The judicial freezing was due to a recovery rights dispute with Guangxi Investment Group Co., Ltd., with a debt amounting to 7,351,765.56 yuan [3][5]. - Recent legal actions include a financial loan contract dispute with Guangxi Beibu Gulf Bank, resulting in additional shares being frozen [4][5]. Company Operations and Governance - The company maintains independence from its major shareholder and concerted action parties in terms of assets, business, finance, personnel, and institutions [6]. - The company asserts that the judicial actions against the major shareholder will not significantly impact its daily governance or operations [6]. - The company plans to enhance internal controls and management practices to ensure stable operations and governance amid these challenges [6].
北海国发川山生物股份有限公司关于大股东的一致行动人持有公司的部分股份被司法轮候冻结及标记的公告